Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
MacFie J, Reddy BS, Gatt M, et al
While much research focuses on bariatric surgery patients, the mechanisms of B12 deficiency during rapid weight loss overlap significantly with GLP-1 therapy
Why Compounding Access Is Not an Established Path Positioning in the Metabolic Medicine Conversation For physicians fielding patient questions about 5-amino-1MQ, the appropriate framing: Promising mechanism with solid preclinical rationale Early clinical development human efficacy and safety not yet well characterized No legitimate clinical access pathway in the United States as of 2026 Alternative evidence-based options exist for the underlying metabolic optimization goals patients typically pursue Key Takeaways 5-amino-1MQ is a small-molecule NNMT inhibitor, not a peptide
Key Fact #1: Age-Related Factors Affecting B12 Absorption Several things change with age that make it harder to absorb B12
US$ 24.20
US$ 22.55
US$ 26.83
US$ 24.88
US$ 28.85
US$ 29.48
US$ 25.18